In addition, CRP may mediate carcinogenesis and cancer progression via activation of the FcgRs/MAPK/ERK, FcgRs/NF-κB/NLRP3, and FcgRs/IL-6/AKT/STAT3 pathways (12). This evidence concerns the gene STAT3 and cancer.